Embring, A.;                     Onjukka, E.;                     Mercke, C.;                     Lax, I.;                     Berglund, A.;                     Friesland, S.    
        Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects. Cancers 2023, 15, 2580.
    https://doi.org/10.3390/cancers15092580
    AMA Style
    
                                Embring A,                                 Onjukka E,                                 Mercke C,                                 Lax I,                                 Berglund A,                                 Friesland S.        
                Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects. Cancers. 2023; 15(9):2580.
        https://doi.org/10.3390/cancers15092580
    
    Chicago/Turabian Style
    
                                Embring, Anna,                                 Eva Onjukka,                                 Claes Mercke,                                 Ingmar Lax,                                 Anders Berglund,                                 and Signe Friesland.        
                2023. "Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects" Cancers 15, no. 9: 2580.
        https://doi.org/10.3390/cancers15092580
    
    APA Style
    
                                Embring, A.,                                 Onjukka, E.,                                 Mercke, C.,                                 Lax, I.,                                 Berglund, A.,                                 & Friesland, S.        
        
        (2023). Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects. Cancers, 15(9), 2580.
        https://doi.org/10.3390/cancers15092580